β-blockers in Heart Failure - Pharmacy benefit management

Implementation of treatment guideline recommendations (refer to PBM-MAP Clinical Practice Guideline for the Pharmacologic Management of Chronic Heart Failure in Primary Care Practice at www.oqp.med.va.gov) should be emphasized in order to provide patients with the opportunity for optimal drug therapy benefit.8. Bisoprolol ................
................